Alkermes Plc 's

• ALKS's Stock Performance relative to its Competitors

Zevra Therapeutics Inc Share Performance +4.38% 30 Days

Zevra Therapeutics Inc Profile Zevra Therapeutics Inc operates on a business model that focuses on the development and commercialization of innovative therapeutics. More about Zevra Therapeutics Inc 's Market Share

Climb Bio Inc Share Performance +549.37% One Year

Climb Bio Inc Profile The company develops clinical-stage therapeutics targeting immune-mediated diseases through the use of monoclonal antibodies. More about Climb Bio Inc 's Market Share

Clene Inc Share Performance -36.15% One Year

Clene Inc Profile Clene Inc's business model focuses on developing and commercializing novel nanocatalysts to enhance energy storage systems and improve the efficiency and performance of clean energy technologies. More about Clene Inc 's Market Share

Biomarin Pharmaceutical Inc Share Performance +2.88% Over The Past 5 Days

Biomarin Pharmaceutical Inc Profile Biomarin Pharmaceutical Inc operates as a biotechnology company, specializing in the development and commercialization of innovative therapies for rare genetic diseases. Their business model revolves around conducting extensive research and development to identify and address unmet medical needs, manufacturing and marketing their approved products, and collaborating with strategic partners to maximize the reach and impact of their therapies worldwide. By focusing on rare diseases, Biomarin leverages their expertise to provide targeted and innovative treatments, ultimately improving the lives of patients in need. More about Biomarin Pharmaceutical Inc's Market Share

Axsome Therapeutics Inc Share Performance +65.12% One Year

Axsome Therapeutics Inc Profile Axsome Therapeutics Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for central nervous system (CNS) disorders. Their business model revolves around conducting clinical trials to demonstrate the safety and efficacy of their drug candidates, obtaining regulatory approvals, and subsequently marketing and selling these therapies in the market to improve patient outcomes and generate revenue. By targeting CNS disorders, Axsome Therapeutics aims to address unmet medical needs and provide solutions for patients suffering from these conditions. More about Axsome Therapeutics Inc 's Market Share

Sources: Alkermes Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Sunday, September 6, 2026 5:14 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Alkermes Plc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.